Deltec Asset Management LLC Horizon Therapeutics Public LTD CO Transaction History

Deltec Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 26, 2022	SELL	$58.92 - $84.67 $841,377 - $1.21 Million	-14,280 Reduced 16.5%	72,290 $4.47 Million
Q2 2022 Jul 18, 2022	BUY	$79.4 - $116.36 $3.1 Million - $4.55 Million	39,100 Added 82.37%	86,570 $6.91 Million
Q1 2022 Apr 11, 2022	SELL	$86.42 - $109.81 $1.63 Million - $2.07 Million	-18,840 Reduced 28.41%	47,470 $4.99 Million
Q4 2021 Jan 25, 2022	SELL	$98.56 - $119.91 $43,366 - $52,760	-440 Reduced 0.66%	66,310 $7.15 Million
Q3 2021 Oct 13, 2021	SELL	$91.91 - $110.37 $7.16 Million - $8.59 Million	-77,850 Reduced 53.84%	66,750 $7.31 Million
Q1 2021 Apr 21, 2021	SELL	$71.83 - $95.48 $215,490 - $286,440	-3,000 Reduced 2.03%	144,600 $13.3 Million
Q4 2020 Jan 20, 2021	BUY	$67.0 - $84.39 $3.36 Million - $4.23 Million	50,100 Added 51.38%	147,600 $10.8 Million
Q3 2020 Oct 23, 2020	BUY	$55.23 - $79.93 $5.38 Million - $7.79 Million	97,500 New	97,500 $7.57 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Deltec Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Deltec Asset Management LLC with notifications on news.